Science Explorer Back to mapMap
Discussion
Company · Paris · France

HRA Pharma (France)

hra-pharma.comROR OpenAlex
Research works
30
▲ 70% vs 2018-21
Citations
1k
33.6 per fractional work
Top-10% rate
11.5%
all institutions 10.0%
Open access
44%
world 40%
International
40%
world 18%
HRA Pharma (France)

Not ranked overall: HRA Pharma (France) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does HRA Pharma (France) work in?

In all years, 82% of research at HRA Pharma (France) is in Health Sciences, 16% in Life Sciences. Its largest fields are Medicine (78%), Biochemistry, Genetics and Molecular Biology (6%), Immunology and Microbiology (4%). It does 2.8× the world's share of Health Sciences.

Health Sciences: 25 fractional works · 82.2% of its workMedicine: 24 fractional works · 77.9% of its workPublic Health, Environmental and Occupational Health: 9 fractional works · 28.9% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 7.3% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 6.3% of its workSurgery: 2 fractional works · 5.4% of its workOncology: 2 fractional works · 5.4% of its workReproductive Medicine: 1 fractional works · 4.2% of its workPhysiology: 1 fractional works · 3.6% of its workDermatology: 1 fractional works · 2.3% of its workObstetrics and Gynecology: 1 fractional works · 2.0% of its workPathology and Forensic Medicine: 1 fractional works · 2.0% of its workEpidemiology: 0 fractional works · 1.6% of its workHematology: 0 fractional works · 1.6% of its workPsychiatry and Mental health: 0 fractional works · 1.3% of its workTransplantation: 0 fractional works · 1.1% of its workNeurology: 0 fractional works · 0.8% of its workEmergency Medicine: 0 fractional works · 0.6% of its workFamily Practice: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.5% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.3% of its workInfectious Diseases: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.6% of its workNursing: 1 fractional works · 2.2% of its workNutrition and Dietetics: 1 fractional works · 2.2% of its workHealth Professions: 1 fractional works · 2.0% of its workGeneral Health Professions: 0 fractional works · 1.6% of its workComplementary and Manual Therapy: 0 fractional works · 0.4% of its workLife Sciences: 5 fractional works · 16.1% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 6.5% of its workGenetics: 1 fractional works · 3.0% of its workMolecular Biology: 1 fractional works · 2.8% of its workCancer Research: 0 fractional works · 0.7% of its workImmunology and Microbiology: 1 fractional works · 4.1% of its workMicrobiology: 1 fractional works · 3.5% of its workImmunology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.8% of its workToxicology: 1 fractional works · 2.0% of its workPharmacology: 0 fractional works · 0.6% of its workPharmaceutical Science: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 2.2% of its workNeurology: 0 fractional works · 0.9% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.6% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workBehavioral Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workFood Science: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 0.8% of its workSociology and Political Science: 0 fractional works · 0.8% of its workPsychology: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.0% of its workPhysical Sciences: 0 fractional works · 0.7% of its workChemistry: 0 fractional works · 0.4% of its workOrganic Chemistry: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.4% of its workALL ITS WORKHRA Pharma(France)30fractional works, all years
Life Sciences16%Physical Sciences1%Health Sciences82%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine2477.9%
    2. Nursing12.2%
    3. Health Professions12.0%
    1. Biochemistry, Genetics and Molecular Biology26.5%
    2. Immunology and Microbiology14.1%
    3. Pharmacology, Toxicology and Pharmaceutics12.8%
    4. Neuroscience12.2%
    5. Agricultural and Biological Sciences00.6%
    1. Social Sciences00.8%
    2. Psychology00.1%
    3. Decision Sciences00.0%
    1. Chemistry00.4%
    2. Materials Science00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.62× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.92× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 2.93× its world share, 0 worksImmunology and Micro…Neuroscience: 3.03× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 26.14× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.25× its world share, 0 worksChemistryMaterials Science: 0.42× its world share, 0 worksMaterials ScienceHealth Professions: 0.75× its world share, 0 worksHealth ProfessionsMedicine: 2.96× its world share, 3 worksMedicineNursing: 24.40× its world share, 1 worksNursingPsychology: 0.24× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 26.1×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics26.14×0 works
  2. Nursing24.40×1 works
  3. Neuroscience3.03×0 works
  4. Medicine2.96×3 works
  5. Immunology and Microbiology2.93×0 works
  6. Chemistry1.25×0 works
  7. Biochemistry, Genetics and Molecular Biology0.92×0 works
  8. Health Professions0.75×0 works
  9. Agricultural and Biological Sciences0.62×0 works
  10. Materials Science0.42×0 works
  11. Psychology0.24×0 works

Who are the top researchers at HRA Pharma (France)?

Ranked on the quality score, Tracy James and Erin Gainer lead among researchers whose main affiliation is HRA Pharma (France).

  1. 1 Tracy James France · #857,507 worldwide 2.3k citations · 22 works
  2. 2 Erin Gainer France · #1,192,317 worldwide 1.7k citations · 28 works
All ranked researchers at HRA Pharma (France)

What are the most cited papers from HRA Pharma (France)?

The most cited paper from HRA Pharma (France) is "Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis" (Anna F. Glasier, Sharon Tracey Cameron, Paul M Fine et al., 2010), with 530 citations. Next come "Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study" (173) and "Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture" (171).

Most cited papers
#PaperReleasedCitations
1 Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis Anna F. Glasier, Sharon Tracey Cameron, Paul M Fine et al. · The Lancet 30 Jan 2010 530
2 Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study Ilse G.C. Hermsen, Martin Faßnacht, Massimo Terzolo et al. · The Journal of Clinical Endocrinology & Metabolism 7 Apr 2011 173
3 Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture Vivian Brache, Leila Cochón, Cristián Jesam et al. · Human Reproduction 15 Jul 2010 171
4 Ulipristal Acetate Taken 48–120 Hours After Intercourse for Emergency Contraception Paul M Fine, Henri Mathé, Savita Y. Ginde et al. · Obstetrics and Gynecology 19 Jan 2010 161
5 A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference Paulus F. Kirchhof et al. · EP Europace Open access 18 Oct 2015 142
All 82 most cited papers, with filters and sorting

Which keywords describe research at HRA Pharma (France)?

By fractional works in all years, weighted toward what it does more of than the world: Family Planning, Reproductive Health, Contraception, Unintended Pregnancy, Fertility, Immunosuppressive Drugs, Metabolic Syndrome and Maternal Mortality.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 34 words, with their numbers
  1. Family Planning6▲ 380×2 topics
  2. Reproductive Health6▲ 455×2 topics
  3. Contraception6▲ 753×1 topic
  4. Unintended Pregnancy6▲ 753×1 topic
  5. Fertility3▲ 107×2 topics
  6. Immunosuppressive Drugs2▲ 104×2 topics
  7. Metabolic Syndrome2▲ 7.6×4 topics
  8. Maternal Mortality2▲ 34×2 topics
  9. Corticosteroid Therapy2▲ 213×2 topics
  10. Inflammatory Bowel Disease2▲ 52×1 topic
  11. Medication Use2▲ 247×1 topic
  12. Oxidative Stress2▲ 3.1×8 topics
  13. Pregnancy2▲ 26×2 topics
  14. Teratogenicity2▲ 84×2 topics
  15. Quality of Life2▲ 3.6×3 topics
  16. Obesity1▲ 6.1×3 topics
  17. Cardiovascular Disease1▲ 4.0×5 topics
  18. Breast Cancer1▲ 14×4 topics
  19. Child Mortality1▲ 67×1 topic
  20. HIV Transmission1▲ 43×2 topics
  21. Health Systems1▲ 67×1 topic
  22. Neurotoxicity1▲ 20×2 topics
  23. Ovarian Reserve1▲ 87×1 topic
  24. Polycystic Ovary Syndrome1▲ 87×1 topic
  25. Risk Factors1▲ 3.3×3 topics
  26. Sexually Transmitted Infections1▲ 62×1 topic
  27. Vaginal Microbiome1▲ 116×1 topic
  28. Chemotherapy-Induced Peripheral Neuropathy1▲ 66×1 topic
  29. Hiccups1▲ 740×1 topic
  30. Inflammation1▲ 1.45×9 topics
  31. Neurological Disorders1▲ 5.1×2 topics
  32. Nuclear Receptors1▲ 19×2 topics
  33. Pharmacological Treatment1▲ 740×1 topic
  34. Taxanes1▲ 66×1 topic

Which research topics does HRA Pharma (France) publish most on?

By volume in 2022-now: Reproductive Health and Contraception, Pregnancy and Medication Impact, Food composition and properties and Pharmacovigilance and Adverse Drug Reactions.

Reproductive Health and …1Reproductive Health and Contraception: 1 fractional worksPregnancy and Medication Impact: 1 fractional worksFood composition and properties: 0 fractional worksPharmacovigilance and Adverse Drug Reactions: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksCancer Cells and Metasta…0Cancer Cells and Metastasis: 0 fractional worksTea Polyphenols and Effects: 0 fractional worksBiochemical Analysis and Sensing Techniques: 0 fractional worksPharmaceutical industry and healthcare: 0 fractional worksCancer, Stress, Anesthesia, and Immune Response: 0 fractional works
Public Health, Environmental and Occupational HealthNutrition and DieteticsToxicologyPathology and Forensic Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Reproductive Health and Contraception Public Health, Environmental and Occupational Health 1 works
  2. 2 Pregnancy and Medication Impact Public Health, Environmental and Occupational Health 1 works
  3. 3 Food composition and properties Nutrition and Dietetics 0 works
  4. 4 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
  5. 5 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  6. 6 Cancer Cells and Metastasis Oncology 0 works
  7. 7 Tea Polyphenols and Effects Pathology and Forensic Medicine 0 works
  8. 8 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 0 works
  9. 9 Pharmaceutical industry and healthcare Pharmacology 0 works
  10. 10 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.5%not open55.5%

World: 40% of research is openly available.

with international co-authors40.1%domestic only59.9%

World: 18% is written across borders.

How has HRA Pharma (France)'s research output changed?

Output in 2022-2025 was 70% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is HRA Pharma (France) as a percentage of every work published that year, 0.000027% in 2024.

still counting0.00010%0.00020%HRA Pharma (France)0.000013% in 20251990200020102020

Fractional works of HRA Pharma (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Paris

All research institutions in Paris

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about HRA Pharma (France). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.